Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial. Supplemental material.
Published: 16 May 2023| Version 1 | DOI: 10.17632/m87sszn9rk.1
Contributor:
Jakob Granild-Jensen
Description
Supplemental Material
Files
Steps to reproduce
See EU Clinical Trials Register, EudraCT Number: 2014-002118-21
Institutions
Aarhus Universitet Health, Regionshospitalet Randers
Categories
Pediatric Endocrinology, Osteoporosis, Bone Metabolism, Patient with Cerebral Palsy, Bisphosphonate